Curative Biotechnology, Inc. (OTCMKTS:CUBT) Short Interest Up 175.0% in March

Curative Biotechnology, Inc. (OTCMKTS:CUBT) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 3,300 shares, an increase of 175.0% from the March 15th total of 1,200 shares. Based on an average daily volume of 91,400 shares, the short-interest ratio is currently 0.0 days.

Curative Biotechnology Price Performance

OTCMKTS:CUBT opened at $0.02 on Friday. Curative Biotechnology has a 12-month low of $0.01 and a 12-month high of $0.04. The firm has a 50-day moving average price of $0.03 and a 200 day moving average price of $0.02.

About Curative Biotechnology

Curative Biotechnology, Inc, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody-drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies.